Moallem H J, Garratty G, Wakeham M, Dial S, Oligario A, Gondi A, Rao S P, Fikrig S
Department of Pediatrics Health Science Center of State University of New York at Brooklyn 11203, USA.
J Pediatr. 1998 Aug;133(2):279-81. doi: 10.1016/s0022-3476(98)70236-7.
A 14-year-old girl with perinatally acquired human immunodeficiency virus infection had fatal intravascular hemolysis after intravenous administration of ceftriaxone. Laboratory studies confirmed the presence of an antibody against ceftriaxone in the serum and on the patient's red blood cells. No evidence of sepsis, glucose-6-phosphate dehydrogenase deficiency or anaphylaxis was found.
一名14岁围产期感染人类免疫缺陷病毒的女孩在静脉注射头孢曲松后发生致命性血管内溶血。实验室检查证实血清及患者红细胞上存在抗头孢曲松抗体。未发现败血症、葡萄糖-6-磷酸脱氢酶缺乏或过敏反应的证据。